Form 4: MDWerks Director Timothy Brocopp Increases Stake Through Share Grant
Insider Transaction Report
MDWerks, Inc. Director Timothy Brocopp acquired 42,383 shares of common stock at $0.27 per share as part of a pre-existing employment agreement.
Summary
- Timothy Brocopp, a Director of MDWerks, Inc. (MDWK), acquired 42,383 shares of common stock.
- The transaction occurred on June 2, 2025, with shares valued at $0.27 each.
- This acquisition was a grant of shares issued on a quarterly basis, pursuant to an Employment Agreement entered into between Mr. Brocopp and MDWerks on November 18, 2024.
- The grant was approved by MDWerks' board of directors and issued in accordance with Rule 16b-3 under the Securities Exchange Act of 1934.
- Following this transaction, Timothy Brocopp directly beneficially owns 2,880,478 shares of MDWerks common stock.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive. While it's a compensation grant rather than an open market purchase, a director increasing their stake, even through a pre-arranged plan, generally signals continued commitment and alignment with shareholder interests. The board approval also indicates proper governance.
Positives
- A director increasing their beneficial ownership, even through a grant, can signal continued alignment with shareholder interests.
- The share grant was approved by the Issuer's board of directors, indicating proper corporate governance for this compensation.
Future Outlook
The document indicates that the grant of shares is issued on a quarterly basis, suggesting similar future grants may occur as per the employment agreement.
Management Comments
- The grant of shares of common stock was issued on a quarterly basis pursuant to the Employment Agreement entered into between Reporting Person and the Issuer on November 18, 2024.
- The grant of shares was approved by the Issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended.
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction, common across all publicly traded companies. It reflects a compensation event for a director rather than a strategic business development or financial performance update.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Approval | The Issuer's board of directors approved the grant of common stock to Director Timothy Brocopp, ensuring compliance with Rule 16b-3. | 06/02/2025 | This demonstrates adherence to established corporate governance practices regarding executive and director compensation. |
Related Party Transactions
- The grant of shares to Director Timothy Brocopp is a related party transaction, as it stems from an Employment Agreement between the director and the company.
Stakeholder Impact
- Shareholders: The increase in a director's beneficial ownership, even through a grant, can be viewed as a positive sign of management's alignment with shareholder interests.
Next Steps
- Future quarterly share grants to Timothy Brocopp are implied by the terms of the Employment Agreement.
Key Dates
| Date | Description |
|---|---|
| 11/18/2024 | Date of Employment Agreement between Timothy Brocopp and MDWerks, Inc. |
| 06/02/2025 | Date of transaction where Timothy Brocopp acquired 42,383 shares of MDWerks common stock. |
| 07/08/2025 | Date the Form 4 was signed by Timothy Brocopp. |
Keywords
MDWerks, MDWK, Timothy Brocopp, Form 4, Insider Transaction, Beneficial Ownership, Common Stock, Director, Share Grant, Employment Agreement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.